BASIC// DISCOVERY

EXCITING FINDINGS on EPILEPSY
Epilepsy, one of the most common
neurological conditions, is characterized
by recurrent seizures prompted by
abnormal, excessively synchronous firing
of neurons in the brain. It may be caused
by abnormal brain connections, an
imbalance of neurotransmitters or changes
in signaling channels within brain cells.
For about 70 percent of patients, seizures
can be controlled with pharmaceutical
treatments. But for many—especially those
who experience prolonged seizures—
current treatments are ineffective and
epilepsy can be life-threatening.
Clinician-scientist Michael Sperling, MD,
Baldwin Keyes Professor of Neurology, is
internationally known for his work in epilepsy
surgery and electrophysiology. He integrates
clinical practice with research, trying to
understand why certain patients benefit from
available treatments—and to identify new,
effective therapies for those who do not. Dr.

Sperling founded and directs the
Jefferson Comprehensive Epilepsy Center,
noted for its basic science and clinical
research on epilepsy’s underlying mechanisms
and on experimental therapeutics. Center
researchers are using electrophysiology,
structural MRI and functional MRI to map
seizure spread within the brain, observe
seizure effects on structures involved in
cognition, memory and language and develop
methods for preventing seizure onset.
Recently, Center researchers found that some
seizures start after a burst from neurons that
inhibit brain activity. In other words, neurons
that dampen other neuronal activity may be key
to starting the large-scale hypersynchrony that
becomes a seizure. The study, which was part
of the group’s search for activation-and-resting
patterns that correlate with more significant
seizures, was the first time that the preseizure neural inhibition was seen in patients.
In the study, performed in collaboration with

neurosurgeons at Jefferson and University of
California at Los Angeles, patients undergoing
preparation for epilepsy surgery had electrodes
placed in the brain to determine the exact
location of seizure onset. The electrodes then
captured signals from the individual excitatory
and inhibitory neurons involved in the seizures.
Analysis of cell signaling showed that inhibitory
neurons fired immediately prior to the excessive
discharge of excitatory neurons. This inhibitory
burst may increase the likelihood of subsequent
hypersynchronous firing that leads to a seizure.
Among the researchers’ goals in leveraging
these findings is to develop a way to use the
pre-inhibition phenomenon as a biomarker
for determining who will (and will not)
respond to seizure-prevention therapy. Other
biomarkers are also being investigated—
in particular, functional MRI signals—in
hopes of better predicting response to
therapy and developing new methods of
modifying abnormal neuronal firing.
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